diclofenac has been researched along with amoxicillin in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (2.94) | 18.2507 |
| 2000's | 10 (29.41) | 29.6817 |
| 2010's | 19 (55.88) | 24.3611 |
| 2020's | 4 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Avdeef, A; Tam, KY | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Pillans, PI | 1 |
| Blum, AL; Bolten, WW; Dragosics, B; Koelz, HR; Labenz, J; Rösch, W; Stolte, M | 1 |
| de Andrade, ED; Groppo, FC; Mattos-Filho, TR; Ramacciato, JC; Rehder, V; Simões, RP | 1 |
| Ambrosano, GM; Cogo, K; de Cássia Bergamaschi, C; Del Fiol, Fde S; Franco, GC; Groppo, FC; Montan, MF; Motta, RH; Rosalen, PL | 1 |
| Chan, FK; Ching, JY; Lau, W; Lee, IY; Lee, KK; You, JH; Yung, M | 1 |
| Belgiorno, V; Guida, M; Kassinos, D; Meriç, S; Naddeo, V | 1 |
| Belgiorno, V; Guida, M; Kassinos, D; Meric, S; Rizzo, L | 1 |
| Camiña, JM; Cantarelli, MA; Marchevsky, EJ; Pellerano, RG | 1 |
| Arizono, K; Matsuo, H; Sakamoto, H; Shinohara, R | 1 |
| Manasadeepa, R; Mukherjee, B; Paul, P | 1 |
| Ballesteros, F; Belgiorno, V; Naddeo, V; Secondes, MF | 1 |
| Faria, JL; Moreira, NF; Nunes, OC; Orge, CA; Pereira, MF; Ribeiro, AR; Silva, AM | 1 |
| Angolkar, T; Buttar, HS; Kaur, G; Yadav, R | 1 |
| Chauhan, M; Saini, VK; Suthar, S | 1 |
| Abualnaja, KM; Ahmed, IA; AlMasoud, N; H Ragab, A; Hussein, HS | 1 |
| Alizadeh, H; Moradi, O; Sedaghat, S | 1 |
| Chyoshi, B; García, J; Gomes Coelho, LH; Subtil, EL | 1 |
1 review(s) available for diclofenac and amoxicillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for diclofenac and amoxicillin
| Article | Year |
|---|---|
Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial.
Topics: Adult; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Diclofenac; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pain; Peptic Ulcer; Treatment Outcome | 2002 |
Effect of sodium diclofenac on the bioavailability of amoxicillin.
Topics: Adult; Amoxicillin; Biological Availability; Cross-Over Studies; Diclofenac; Drug Interactions; Humans; Male | 2006 |
31 other study(ies) available for diclofenac and amoxicillin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Drug associated hepatic reactions in New Zealand: 21 years experience.
Topics: Adult; Adverse Drug Reaction Reporting Systems; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anesthetics, Inhalation; Anti-Bacterial Agents; Anti-Inflammatory Agents; Calcium Channel Blockers; Cardiovascular Agents; Cause of Death; Clavulanic Acids; Diclofenac; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Erythromycin; Female; Floxacillin; Halothane; Humans; Liver; Male; Middle Aged; New Zealand; Penicillins; Perhexiline; Steroids | 1996 |
Effect of sodium diclofenac on serum and tissue concentration of amoxicillin and on staphylococcal infection.
Topics: Amoxicillin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Drug Interactions; Granuloma; Male; Microbial Sensitivity Tests; Penicillins; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus | 2004 |
Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; China; Clarithromycin; Cohort Studies; Cost-Benefit Analysis; Diclofenac; Drug Administration Schedule; Female; Health Care Costs; Health Services; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Risk Factors | 2006 |
Fate of pharmaceuticals in contaminated urban wastewater effluent under ultrasonic irradiation.
Topics: Aerobiosis; Amoxicillin; Animals; Biodegradation, Environmental; Carbamazepine; Catalysis; Chlorophyta; Cities; Daphnia; Diclofenac; Hydrogen Peroxide; Hydrogen-Ion Concentration; Kinetics; Lepidium sativum; Pharmaceutical Preparations; Ultrasonics; Waste Disposal, Fluid; Water Pollutants, Chemical | 2009 |
Heterogenous photocatalytic degradation kinetics and detoxification of an urban wastewater treatment plant effluent contaminated with pharmaceuticals.
Topics: Amoxicillin; Animals; Carbamazepine; Chlorophyta; Cities; Daphnia; Diclofenac; Drug Industry; Industrial Waste; Kinetics; Lepidium sativum; Pharmaceutical Preparations; Photolysis; Toxicity Tests; Waste Disposal, Fluid; Water; Water Pollutants, Chemical | 2009 |
Simultaneous determination of amoxicillin and diclofenac in pharmaceutical formulations using UV spectral data and the PLS chemometric method.
Topics: Amoxicillin; Diclofenac; Least-Squares Analysis; Pharmaceutical Preparations; Spectrophotometry, Ultraviolet | 2011 |
Behavior of pharmaceuticals in waste water treatment plant in Japan.
Topics: Acetaminophen; Amoxicillin; Ampicillin; Carbamazepine; Chromatography, Liquid; Diclofenac; Famotidine; Japan; Ketoprofen; Losartan; Mass Spectrometry; Oseltamivir; Sewage; Trimethoprim; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2011 |
Pressure-sensitive mucoadhesive polymer-based dental patches to treat periodontal diseases: an in vitro study.
Topics: Adhesiveness; Administration, Buccal; Amoxicillin; Animals; Diclofenac; Drug Delivery Systems; Drug Stability; Excipients; Goats; Mouth Mucosa; Periodontal Diseases; Polymers; Pressure; Solubility; Spectroscopy, Fourier Transform Infrared | 2013 |
Removal of emerging contaminants by simultaneous application of membrane ultrafiltration, activated carbon adsorption, and ultrasound irradiation.
Topics: Adsorption; Amoxicillin; Carbamazepine; Carbon; Diclofenac; Membranes, Artificial; Pharmaceutical Preparations; Sound; Ultrafiltration; Water Pollutants, Chemical; Water Purification | 2014 |
Fast mineralization and detoxification of amoxicillin and diclofenac by photocatalytic ozonation and application to an urban wastewater.
Topics: Amoxicillin; Catalysis; Diclofenac; Escherichia coli; Oxidation-Reduction; Ozone; Photolysis; Staphylococcus aureus; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Water Purification | 2015 |
Antibacterial and Antiinflammatory Properties of Bovine Colostrum.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Bacteria; Carrageenan; Cattle; Colostrum; Diclofenac; Disease Models, Animal; Disk Diffusion Antimicrobial Tests; Edema; Inflammation; Rats, Wistar | 2016 |
Ti-pillared montmorillonite clay for adsorptive removal of amoxicillin, imipramine, diclofenac-sodium, and paracetamol from water.
Topics: Acetaminophen; Adsorption; Amoxicillin; Bentonite; Clay; Diclofenac; Imipramine; Kinetics; Sodium; Titanium; Water; Water Pollutants, Chemical | 2020 |
An Efficient Strategy for Enhancing the Adsorption of Antibiotics and Drugs from Aqueous Solutions Using an Effective Limestone-Activated Carbon-Alginate Nanocomposite.
Topics: Adsorption; Alginates; Amoxicillin; Anti-Bacterial Agents; Calcium Carbonate; Charcoal; Diclofenac; Hydrogen-Ion Concentration; Kinetics; Nanocomposites; Pharmaceutical Preparations; Porosity; Solutions; Water; Water Pollutants, Chemical; Water Purification | 2021 |
Removal of pharmaceuticals (diclofenac and amoxicillin) by maltodextrin/reduced graphene and maltodextrin/reduced graphene/copper oxide nanocomposites.
Topics: Adsorption; Amoxicillin; Copper; Diclofenac; Graphite; Kinetics; Nanocomposites; Pharmaceutical Preparations; Polysaccharides; Spectroscopy, Fourier Transform Infrared; Water; Water Pollutants, Chemical | 2022 |
Fate and removal of emerging contaminants in anaerobic fluidized membrane bioreactor filled with thermoplastic gel as biofilm support.
Topics: Amoxicillin; Anaerobiosis; Biofilms; Bioreactors; Diclofenac; Estradiol; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical | 2022 |